Literature DB >> 21564165

Effect of lamotrigine on the PR interval in healthy subjects.

Ruth Dixon, Sarah Alexander, Neil Brickel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21564165      PMCID： PMC3099385          DOI： 10.1111/j.1365-2125.2010.03855.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

1.  Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects.

Authors:  Ruth Dixon; Sarah Job; Ruth Oliver; Debra Tompson; John G Wright; Kay Maltby; Ulrike Lorch; Jorg Taubel
Journal:  Br J Clin Pharmacol       Date:  2008-07-23       Impact factor: 4.335

2.  Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group.

Authors:  F Matsuo; D Bergen; E Faught; J A Messenheimer; A T Dren; G D Rudd; C G Lineberry
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

3.  Cardiac function and antiepileptic drug treatment in the elderly: a comparison between lamotrigine and sustained-release carbamazepine.

Authors:  Erik Saetre; Mikael Abdelnoor; Jan Peder Amlie; Morten Tossebro; Emilio Perucca; Erik Taubøll; Ole Gunnar Anfinsen; Jouko Isojärvi; Leif Gjerstad
Journal:  Epilepsia       Date:  2009-03-23       Impact factor: 5.864
  3 in total
  5 in total

1.  Risk of cardiac events in Long QT syndrome patients when taking antiseizure medications.

Authors:  David S Auerbach; Yitschak Biton; Bronislava Polonsky; Scott McNitt; Robert A Gross; Robert T Dirksen; Arthur J Moss
Journal:  Transl Res       Date:  2017-10-20       Impact factor: 7.012

2.  Evaluation of Cardiovascular Concerns of Intravenous Lacosamide Therapy in Epilepsy Patients.

Authors:  Yan-Ting Lu; Chih-Hsiang Lin; Chen-Jui Ho; Che-Wei Hsu; Meng-Han Tsai
Journal:  Front Neurol       Date:  2022-07-04       Impact factor: 4.086

3.  Cardiac sodium channel inhibition by lamotrigine: In vitro characterization and clinical implications.

Authors:  Lindsey Ingleby-Talecki; Sven C van Dijkman; Sean P Oosterholt; Oscar Della Pasqua; Christina Winter; Marianne Cunnington; Linda Rebar; Sergio Forero-Schwanhaeuser; Vickas Patel; James A Cooper; Anthony Bahinski; Khuram W Chaudhary
Journal:  Clin Transl Sci       Date:  2022-05-31       Impact factor: 4.438

4.  FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force.

Authors:  Jacqueline A French; Emilio Perucca; Josemir W Sander; Lennart Bergfeldt; Michel Baulac; David S Auerbach; Mark Keezer; Roland D Thijs; Orrin Devinsky; David G Vossler; Timothy E Welty
Journal:  Epilepsia Open       Date:  2021-02-25

Review 5.  Neuropharmacology of Antiseizure Drugs.

Authors:  Tahir Hakami
Journal:  Neuropsychopharmacol Rep       Date:  2021-07-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.